Clinical Trials Browser

Phase 4 × Lymphoma, Large B-Cell, Diffuse × Rituximab × Clear all

NCT02752815 2022-12-05

Reduced Chemotherapy in Low Risk DLBCL

Phase 4 Unknown

Lymphoma, Large B-Cell, Diffuse